Skip to content
★ Sign in to follow
DF

Danina Fisher

Executive
Hepion Pharmaceuticals, Inc.
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€8,794
▼ Sales (0 ops.)
—

Latest filing published 02 Oct 2026 for Hepion Pharmaceuticals, Inc., €8,794.

Filing timeline

BuySale
Danina Fisher

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Danina Fisher: trading record in brief

Our data holds just one disclosure by Danina Fisher, dated 2 October 2026, reporting an open-market purchase worth €8,794 in Hepion Pharmaceuticals, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Danina Fisher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    DirectorExecutivesHepion Pharmaceuticals, Inc.
    10,000 USD28SEC
    200,000 shares@ US$0.050.11% mcap100.0% of flowCommon StockSEC:0001493152-26-045526:0
    Canonical exit: 28 Dec 2026 (T+90)

1 of 1 declaration